Home Cart Sign in  
Chemical Structure| 162359-55-9 Chemical Structure| 162359-55-9

Structure of Fingolimod
CAS No.: 162359-55-9

Chemical Structure| 162359-55-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fingolimod (FTY720 free base) is a sphingosine 1-phosphate (S1P) antagonist with an IC50 of 0.033 nM in K562 and NK cells. Fingolimod is also a Pak1 activator and an immunosuppressant.

Synonyms: FTY720 free base; FTY-720; FTY720 (free base)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Fingolimod

CAS No. :162359-55-9
Formula : C19H33NO2
M.W : 307.47
SMILES Code : OCC(CCC1=CC=C(CCCCCCCC)C=C1)(N)CO
Synonyms :
FTY720 free base; FTY-720; FTY720 (free base)
MDL No. :MFCD14705150

Safety of Fingolimod

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Fingolimod

GPCR

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03535298 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 4 Not yet recruiting September 2023 United States, Ohio ... More >> Cleveland Clinic Not yet recruiting Cleveland, Ohio, United States, 44195 Contact: Tammy Skaramagas, BA    216-445-6724    skaramt1@ccf.org    Principal Investigator: Daniel Ontaneda, MD, MSc          United Kingdom University of Nottingham Not yet recruiting Nottingham, United Kingdom, NG7 2UH Contact: Sara Wilkins    +44 115 9249924 ext 66816    Sara.wilkins@nuh.nhs.uk    Principal Investigator: Nikos Evangelou, MD, DPhil Less <<
NCT01795872 Multiple Sclerosis Phase 4 Completed - -
NCT03500328 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Not Applicable Recruiting October 31, 2022 -
NCT03193866 - Recruiting December 2021 Sweden ... More >> Fredrik Piehl Recruiting Stockholm, Sweden Contact: Fredrik Piehl, Professor    +46 73-671 81 01    Fredrik.Piehl@ki.se    Contact: Anna Fogdell-Hahn, PhD    +46 70-544 90 60    anna.fogdell-hahn@ki.se Less <<
NCT02559765 - Completed - United Kingdom ... More >> The University of Glasgow Glasgow, United Kingdom, G12 8LL Less <<
NCT02241785 Relapsing Multiple Sclerosis Phase 4 Terminated(Business Decision) - United States, California ... More >> Research Site Fullerton, California, United States, 92835 United States, Colorado Research Site Aurora, Colorado, United States, 80045 United States, Iowa Research Site Des Moines, Iowa, United States, 50314 United States, Missouri Research Site Saint Louis, Missouri, United States, 63110 United States, New York Research Site Plainview, New York, United States, 11803 United States, North Carolina Research Site Raleigh, North Carolina, United States, 27607-6010 United States, Ohio Research Site Akron, Ohio, United States, 44320 Research Site Cleveland, Ohio, United States, 44195 United States, Tennessee Research Site Knoxville, Tennessee, United States, 37922 United States, Texas Research Site Round Rock, Texas, United States, 78681 United States, Washington Research Site Tacoma, Washington, United States, 98405 Less <<
NCT00273364 Multiple Sclerosis Phase 2 Active, not recruiting December 2018 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT02139696 - Completed - Finland ... More >> Turku University Hospital Turku, Finland, 20520 Less <<
NCT02193217 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 1 Completed - United Kingdom ... More >> Investigational site Leeds, United Kingdom Less <<
NCT02241785 - Terminated(Business Decision) - -
NCT02408380 - Unknown December 2015 Canada, Quebec ... More >> McGill University Recruiting Montreal, Quebec, Canada, H3A 2B4 Contact: Leslie Fitz-Gerald, MSc    5143987192 ext 00510    leslie.fitz-gerald@mail.mcgill.ca    Principal Investigator: David Haegert, MD Less <<
NCT02141022 Multiple Sclerosis ... More >> Cognitive Deficits Gilenya Modifying Therapy for MS Less << Not Applicable Completed - United States, New York ... More >> Stony Brook University Stony Brook, New York, United States, 11794 Less <<
NCT03399981 - Active, not recruiting December 31, 2023 United States, Massachusetts ... More >> Research Site Cambridge, Massachusetts, United States, 02142 Less <<
NCT00098735 Kidney Transplantation Phase 3 Completed - -
NCT00239785 Renal Transplantation Phase 3 Completed - -
NCT00239798 Renal Transplantation Phase 2 Completed - -
NCT00239902 Renal Transplantation Phase 2 Completed - -
NCT02776072 - Completed - -
NCT00099749 Kidney Transplantation Phase 2 Phase 3 Completed - United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 SIU School of Medicine Springfield, Illinois, United States, 62781 United States, New Jersey St. Barnabas Medical Center Livingston, New Jersey, United States, 07039 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Rhode Island Rhode Island Hospital Providence, Rhode Island, United States, 02903 Less <<
NCT00099801 Kidney Transplantation Phase 3 Completed - -
NCT00239811 Renal Transplantation Phase 3 Completed - -
NCT00239876 Renal Transplantation Phase 3 Completed - -
NCT01709812 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 4 Withdrawn July 2013 -
NCT01592097 - Completed - United States, California ... More >> Keck School of Medicine of the University of Southern Calfornia Los Angeles, California, United States, 90033 Less <<
NCT01705236 Relapsing Remitting Multiple S... More >>clerosis RRMS Less << PHASE4 COMPLETED 2019-02-18 Novartis Investigative Site, B... More >>ochum, 44791, Germany|Novartis Investigative Site, Bonn, 53105, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Duesseldorf, 40225, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Rostock, 18057, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Zuerich, 8091, Switzerland Less <<
NCT02335892 - Completed - United Kingdom ... More >> Novartis Investigative Site Truro, Cornwall, United Kingdom, TR1 3LJ Novartis Investigative Site Swansea, England, United Kingdom, SA6 6NL Novartis Investigative Site Romford, Essex, United Kingdom, RM7 0AG Novartis Investigative Site Basingstoke, Hampshire, United Kingdom, RG24 9NA Novartis Investigative Site Edinburgh, United Kingdom, EH16 4SA Novartis Investigative Site Glasgow, United Kingdom, G51 4TF Novartis Investigative Site Leicester, United Kingdom, LE5 4PW Novartis Investigative Site Liverpool, United Kingdom, L9 7LT Novartis Investigative Site London, United Kingdom, E1 1BB Novartis Investigative Site London, United Kingdom, SW17 0QT Novartis Investigative Site London, United Kingdom, W6 8RF Novartis Investigative Site London, United Kingdom, WC1N 3BG Novartis Investigative Site Norwich, United Kingdom, NR4 7UY Novartis Investigative Site Nottingham, United Kingdom, NG5 1PB Less <<
NCT01127750 Relapsing Multiple Sclerosis Phase 3 Completed - -
NCT00416845 Healthy Phase 1 Completed - United States, New Jersey ... More >> Novartis Investigative Site East Hanover, New Jersey, United States, 07936-1080 Less <<
NCT01490840 Fatigue in Multiple Sclerosis Phase 4 Terminated(The study stopped d... More >>ue to slow enrollment and low participant compliance.) Less << - Germany ... More >> Novartis Investigative Site Aachen, Germany, 52062 Novartis Investigative Site Alzenau, Germany, 63755 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Bad Mergentheim, Germany, 97980 Novartis Investigative Site Bamberg, Germany, 96052 Novartis Investigative Site Bayreuth, Germany, 95445 Novartis Investigative Site Berlin, Germany, 10437 Novartis Investigative Site Berlin, Germany, 10625 Novartis Investigative Site Berlin, Germany, 10691 Novartis Investigative Site Berlin, Germany, 12587 Novartis Investigative Site Berlin, Germany, 13347 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44787 Novartis Investigative Site Böblingen, Germany, 71032 Novartis Investigative Site Dortmund, Germany, 44135 Novartis Investigative Site Erbach, Germany, 64711 Novartis Investigative Site Erlangen, Germany, 91054 Novartis Investigative Site Frankfurt, Germany, 65929 Novartis Investigative Site Hamburg, Germany, 22179 Novartis Investigative Site Heidelberg, Germany, 69120 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Kassel, Germany, 34121 Novartis Investigative Site Leipzig, Germany, 04299 Novartis Investigative Site Potsdam, Germany, 14471 Novartis Investigative Site Prien, Germany, 83209 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Siegen, Germany, 57076 Novartis Investigative Site Sinsheim, Germany, 74889 Novartis Investigative Site Stuttgart, Germany, 70174 Novartis Investigative Site Stuttgart, Germany, 70178 Novartis Investigative Site Teupitz, Germany, 15755 Novartis Investigative Site Unterhaching, Germany, 82008 Less <<
NCT00785083 Asthma Phase 2 Completed - United Kingdom ... More >> Novartis Investigator Site Manchester, United Kingdom Less <<
NCT00099736 Kidney Transplantation Phase 3 Completed - -
NCT01704183 - Completed - Finland ... More >> Neuro Center, Kuopio University Hospital Kuopio, Finland Department of Neurology, Mikkeli Central Hospital Mikkeli, Finland Less <<
NCT02720107 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Ostfildern, Baden-Wuerttemberg, Germany, 73760 Novartis Investigative Site Altenholz-Stift, Germany, 24161 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Berlin, Germany, 10713 Novartis Investigative Site Berlin, Germany, 12163 Novartis Investigative Site Berlin, Germany, 13347 Novartis Investigative Site Böblingen, Germany, 71032 Novartis Investigative Site Celle, Germany, 29223 Novartis Investigative Site Dortmund, Germany, 44137 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Erbach, Germany, 64711 Novartis Investigative Site Frankfurt, Germany, 60313 Novartis Investigative Site Göttingen, Germany, 37073 Novartis Investigative Site Jena, Germany, 07740 Novartis Investigative Site Kiel, Germany, 24105 Novartis Investigative Site Klingenmünster, Germany, 76889 Novartis Investigative Site Lappersdorf, Germany, 93138 Novartis Investigative Site Leverkusen, Germany, 51375 Novartis Investigative Site Mönchengladbach, Germany, 41239 Novartis Investigative Site München, Germany, 81829 Novartis Investigative Site Neuburg an der Donau, Germany, 86633 Novartis Investigative Site Siegen, Germany, 57076 Novartis Investigative Site Singen, Germany, 78224 Novartis Investigative Site Troisdorf, Germany, 53844 Novartis Investigative Site Ulm, Germany, 89073 Novartis Investigative Site Unterhaching, Germany, 82008 Less <<
NCT03243721 Multiple Sclerosis Not Applicable Active, not recruiting December 2019 United States, Ohio ... More >> Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Less <<
NCT00239863 Renal Transplantation Phase 3 Completed - -
NCT02307838 Multiple Sclerosis, Relapsing ... More >>Forms of Multiple Sclerosis Less << Phase 4 Completed - Canada, Ontario ... More >> Novartis Investigative Site Ottawa, Ontario, Canada, K1H 8L6 Novartis Investigative Site Toronto, Ontario, Canada, M5B 1N9 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H2L 4M1 Novartis Investigative Site Montreal, Quebec, Canada, H3A 2B4 Denmark Novartis Investigative Site Copenhagen, Denmark, DK-2100 Novartis Investigative Site Glostrup, Denmark, DK-2600 France Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Marseille, France, 13385 Germany Novartis Investigative Site Würzburg, Germany, 97080 Italy Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Roma, RM, Italy, 00189 Novartis Investigative Site Gallarate, VA, Italy, 21013 Poland Novartis Investigative Site Warszawa, Poland, 02-097 Novartis Investigative Site Warszawa, Poland, 02-957 Portugal Novartis Investigative Site Coimbra, Portugal, 3000-075 Novartis Investigative Site Lisboa, Portugal, 1150-314 Spain Novartis Investigative Site Malaga, Andalucia, Spain, 29010 Novartis Investigative Site Sevilla, Andalucia, Spain, 41009 Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 Novartis Investigative Site L'Hospitalet de Llobregat, Catalunya, Spain, 08907 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 Novartis Investigative Site Madrid, Spain, 28040 Switzerland Novartis Investigative Site Basel, Switzerland, 4031 Novartis Investigative Site Zuerich, Switzerland, 8091 United Kingdom Novartis Investigative Site Newcastle Upon Tyne, United Kingdom, NE1 4LP Less <<
NCT02277964 - Completed - Switzerland ... More >> University Hospital Basel, Switzerland Basel, Switzerland, 4031 Less <<
NCT01490840 - Terminated(The study stopped d... More >>ue to slow enrollment and low participant compliance.) Less << - -
NCT01285479 Multiple Sclerosis COMPLETED 2024-05-29 Novartis Investigative Site, F... More >>ort Lauderdale, Florida, 33308, United States|Novartis Investigative Site, Cambridge, Massachusetts, 02139, United States|Novartis Investigative Site, Grand Forks, North Dakota, 58201, United States|Novartis Investigative Site, Bahía Blanca, Buenos Aires, 8000, Argentina|Novartis Investigative Site, Cordoba, X5000FAL, Argentina|Novartis Investigative Site, Box Hill, Victoria, 3128, Australia|Novartis Investigative Site, Graz, 8036, Austria|Novartis Investigative Site, Linz, 4020, Austria|Novartis Investigative Site, Brasschaat, 2930, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Rio de Janeiro, RJ, 21941-913, Brazil|Novartis Investigative Site, Saint-Laurent, Quebec, H4M-2P4, Canada|Novartis Investigative Site, Bogotá, Colombia|Novartis Investigative Site, Nicosia, 1683, Cyprus|Novartis Investigative Site, Ostrava-Poruba, 708 52, Czechia|Novartis Investigative Site, Aalborg, 9000, Denmark|Novartis Investigative Site, Aarhus, 8000 C, Denmark|Novartis Investigative Site, Copenhagen, DK-2100, Denmark|Novartis Investigative Site, Soenderborg, 6400, Denmark|Novartis Investigative Site, Tampere, FIN-33521, Finland|Novartis Investigative Site, Turku, 20520, Finland|Novartis Investigative Site, Bron, 69677, France|Novartis Investigative Site, Cahors, 50269, France|Novartis Investigative Site, Bochum, 44791, Germany|Novartis Investigative Site, Athens, GR, 115 25, Greece|Novartis Investigative Site, Budapest, HUN, 1204, Hungary|Novartis Investigative Site, Gyor, H-9023, Hungary|Novartis Investigative Site, Dublin 4, D04 T6F, Ireland|Novartis Investigative Site, Jerusalem, 9112001, Israel|Novartis Investigative Site, Ramat Gan, 52621, Israel|Novartis Investigative Site, Catania, CT, 95123, Italy|Novartis Investigative Site, Firenze, FI, 50134, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Milano, MI, 20132, Italy|Novartis Investigative Site, Roma, RM, 189, Italy|Novartis Investigative Site, Orbassano, TO, 10043, Italy|Novartis Investigative Site, Beirut, 1107 2020, Lebanon|Novartis Investigative Site, Mexico, Distrito Federal, 05300, Mexico|Novartis Investigative Site, Amsterdam, Netherlands|Novartis Investigative Site, Lubin, 20-089, Poland|Novartis Investigative Site, Warszawa, 02-957, Poland|Novartis Investigative Site, Amadora, 2720-276, Portugal|Novartis Investigative Site, Porto, 4099-001, Portugal|Novartis Investigative Site, Bucharest, 050098, Romania|Novartis Investigative Site, Moscow, 127018, Russian Federation|Novartis Investigative Site, Jeddah, 21499, Saudi Arabia|Novartis Investigative Site, Riyadh, 11211, Saudi Arabia|Novartis Investigative Site, Bratislava, Slovak Republic, 811 07, Slovakia|Novartis Investigative Site, Maribor, 2000, Slovenia|Novartis Investigative Site, Sevilla, Andalucia, 41071, Spain|Novartis Investigative Site, Madrid, 28222, Spain|Novartis Investigative Site, Goeteborg, 413 45, Sweden|Novartis Investigative Site, Basel, 4031, Switzerland|Novartis Investigative Site, Bern, 3010, Switzerland|Novartis Investigative Site, Lausanne, 1011, Switzerland|Novartis Investigative Site, St Gallen, 9007, Switzerland|Novartis Investigative Site, Abu Dhabi, United Arab Emirates|Novartis Investigative Site, Dubai, United Arab Emirates|Novartis Investigative Site, Newcastle upon Tyne, NE1 4LP, United Kingdom|Novartis Investigative Site, Norwich, NR1 3SR, United Kingdom|Novartis Investigative Site, Nottingham, NG7 2UH, United Kingdom Less <<
NCT01647880 Multiple Sclerosis Phase 2 Phase 3 Terminated(delayed recruitment... More >>) Less << - Germany ... More >> Charité-Universitätsmedizin Berlin Berlin, Germany Sankt Josefs Krankenhaus Potsdam Neurologie Potsdam, Germany Less <<
NCT02307838 - Completed - -
NCT02225977 - Completed - United States, California ... More >> University of Southern California, Department of Neurology Los Angeles, California, United States, 90033 Less <<
NCT00537082 Multiple Sclerosis Phase 2 Completed - Japan ... More >> Novartis Investigative site Sapporo-shi, Hokkaido, Japan Novartis Investigative Site Chiba, Japan, 276-8524 Novartis Investigative Site Ehime, Japan, 791-0295 Novartis Investigative Site Fukuoka, Japan, 807-8555 Novartis Investigative Site Gunma, Japan, 371-8511 Novartis Investigative Site Hyogo, Japan, 650-0017 Novartis Investigative Site Ibaraki, Japan, 305-8576 Novartis Iwate, Japan, 020-8505 Novartis Investigative Site Kanagawa, Japan, 259-1193 Novartis Investigative Site Kyoto, Japan, 604-8453 Novartis Investigative Site Kyoto, Japan, 616-8255 Novartis Investigative Site Niigata, Japan, 951-8520 Novartis Investigative Site Osaka, Japan, 556-0016 Novartis Investigative Site Osaka, Japan, 589-8511 Novartis Investigative Site Tochigi, Japan, 329-0498 Novartis Investigative Site Tokyo, Japan, 145-0065 Novartis Investigative Site Tokyo, Japan, 162-8666 Novartis Investigative Site Wakayama, Japan, 641-8510 Less <<
NCT00537082 - Completed - -
NCT00731523 Renal Insufficiency Phase 1 Completed - Russian Federation ... More >> Novartis Investigator Site Moscow, Russian Federation Less <<
NCT01811290 - Active, not recruiting December 2018 United States, Washington ... More >> MS Center at Evergreen Health Kirkland, Washington, United States, 98034 Less <<
NCT02307877 - Active, not recruiting December 2019 United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Less <<
NCT00333138 Multiple Sclerosis Phase 2 Completed - Canada ... More >> Novartis Investigational site Montreal, Canada Novartis Investigational site Ottawa, Canada Novartis Investigational site Toronto, Canada Novartis Investigational site Vancouver, Canada Denmark Novartis Investigational site Copenhagen, Denmark Finland Novartis Investigational site Helsinki, Finland Novartis Investigational site Turku, Finland France Novartis Investigational site Lille, France Novartis Investigational site Marseille, France Germany Novartis Investigational site Schwendi, Germany Novartis Investigational site Wurzburg, Germany Italy Novartis Investigational site Gallarate, Italy Novartis Investigational site Genova, Italy Novartis Investigational site Milano, Italy Novartis Investigational site Roma, Italy Poland Novartis Investigational site Warszawa, Poland Portugal Novartis Investigational site Coimbra, Portugal Novartis Investigational site Lisboa, Portugal Spain Novartis Investigational site Barcelona, Spain Novartis Investigational site Madrid, Spain Novartis Investigational site Malaga, Spain Novartis Investigational site Sevilla, Spain Novartis Investigational site Valencia, Spain Switzerland Novartis Investigational site Basel, Switzerland Novartis Investigational site Zurich, Switzerland United Kingdom Novartis Investigational site Newcastle upon Tyne, United Kingdom Less <<
NCT01317004 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Italy ... More >> Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Ponderano, BI, Italy, 13900 Novartis Investigative Site Caltanissetta, CL, Italy, 93100 Novartis Investigative Site Cuneo, CN, Italy, 12100 Novartis Investigative Site Como, CO, Italy, 22100 Novartis Investigative Site Catania, CT, Italy, 95122 Novartis Investigative Site Foggia, FG, Italy, 71100 Novartis Investigative Site Castelfiorentino, FI, Italy, 50051 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site San Donato Milanese, MI, Italy, 20097 Novartis Investigative Site Modena, MO, Italy, 41100 Novartis Investigative Site Palermo, PA, Italy, 90129 Novartis Investigative Site Palermo, PA, Italy, 90146 Novartis Investigative Site Pisa, PI, Italy, 56126 Novartis Investigative Site Legnago, VR, Italy, 37045 Novartis Investigative Site Novara, Italy, 28100 Less <<
NCT00731692 - Terminated(The extension study... More >> was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression) Less << - -
NCT00333138 - Completed - -
NCT01317004 - Completed - -
NCT00731692 Primary Progressive Multiple S... More >>clerosis Less << Phase 3 Terminated(The extension study... More >> was terminated early after the results of the core study showed the study did not meet primary endpoint; confirmed disability progression) Less << - -
NCT02769689 Multiple Sclerosis Phase 4 Unknown November 2017 France ... More >> CHU Clermont-Ferrand Recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr    Principal Investigator: Pierre CLAVELOU Less <<
NCT01981161 - Recruiting November 2017 France ... More >> CHU Besançon Not yet recruiting Besancon, France, 25000 Contact: Eric Berger, MD       lrumbach@chu-besancon.fr    Principal Investigator: Eric Berger, MD          CHU Bordeaux Not yet recruiting Bordeaux, France, 33 000 Contact: Bruno Brochet, MD PHD       bruno.brochet@chu-bordeaux.fr    Principal Investigator: bruno brochet, MD PHD          CHU Caen Not yet recruiting Caen, France, 14033 Contact: Gilles-Louis Defer, MD PHD       defer-gi@chu-caen.fr    Principal Investigator: Gilles-Louis Defer, MD PHD          Chu Lille Not yet recruiting Lille, France, 59037 Contact: Patrick Vermersch, MD PHD          Principal Investigator: Patrick Vermersch, MD PHD          Chu La Timone Not yet recruiting Marseille, France, 13385 Contact: Jean Pelletier, MD PHD          Principal Investigator: Jean Pelletier, MD PHD          CHU Nancy Not yet recruiting Nancy, France, 54035 Contact: Marc Debouverie, MD PHD          Principal Investigator: Marc Debouverie, MD PHD          CHU Nantes Recruiting Nantes, France, 44093 Contact: David Laplaud, MD       david.laplaud@chu-nantes.fr    Principal Investigator: David Laplaud, MD          CHU Nice Not yet recruiting Nice, France, 06002 Contact: Christine Lebrun-Frenay, MD          Principal Investigator: Christine Lebrun-Frenay, MD          CHU Nîmes Not yet recruiting Nimes, France, 30029 Contact: Pierre Labauge, MD PHD          Principal Investigator: Labauge Pierre, MD PHD          CHRU Strasbourg Not yet recruiting Strasbourg, France, 67098 Contact: Jérôme De Seze, MD pHD          Principal Investigator: Jerome De Seze, MD PHD          Germany Université de Muenter Not yet recruiting Munster, Germany Contact: H Wiendl, MD PHD          Principal Investigator: H Wiendl, MD PHD          Spain Hôpital Vall D'Hebron Not yet recruiting Barcelone, Spain Contact: Xavier Montalban, MD PHD          Principal Investigator: XAVIER Montalban, MD PHD Less <<
NCT01436643 Depression Re... More >>lapsing-remitting Multiple Sclerosis Less << Phase 4 Terminated(Due to slow enrollm... More >>ent the study was terminated early) Less << - Germany ... More >> Novartis Investigative Site Achim, Germany, 28832 Novartis Investigative Site Altenholz-Stift, Germany, 24161 Novartis Investigative Site Aschaffenburg, Germany, 63739 Novartis Investigative Site Bad Honnef, Germany, 53604 Novartis Investigative Site Baesweiler, Germany, 52499 Novartis Investigative Site Berlin, Germany, 12621 Novartis Investigative Site Bielefeld, Germany, 33602 Novartis Investigative Site Bielefeld, Germany, 33647 Novartis Investigative Site Bochum, Germany, 44787 Novartis Investigative Site Bremerhaven, Germany, 27574 Novartis Investigative Site Butzbach, Germany, 35510 Novartis Investigative Site Grevenbroich, Germany, 41515 Novartis Investigative Site Heidenheim, Germany, 89518 Novartis Investigative Site Klingenmünster, Germany, 76889 Novartis Investigative Site Leipzig, Germany, 04275 Novartis Investigative Site Merzig, Germany, 66663 Novartis Investigative Site Nienburg, Germany, 31582 Novartis Investigative Site Oberhausen, Germany, 46045 Novartis Investigative Site Oldenburg, Germany, 26122 Novartis Investigative Site Potsdam, Germany, 14471 Novartis Investigative Site Schwalmstadt-Treysa, Germany, 34613 Novartis Investigative Site Stadtroda, Germany, 07646 Novartis Investigative Site Tübingen, Germany, 72076 Novartis Investigative Site Weil am Rhein, Germany, 79576 Novartis Investigative Site Zwickau, Germany, 08060 Less <<
NCT02021162 - Active, not recruiting October 2018 United States, New York ... More >> Buffalo Neuroimaging Analysis Center Buffalo, New York, United States, 14203 Less <<
NCT01436643 - Terminated(Due to slow enrollm... More >>ent the study was terminated early) Less << - -
NCT01892722 Multiple Sclerosis Phase 3 Active, not recruiting March 15, 2023 -
NCT01333501 Multiple Sclerosis Phase 4 Completed - Germany ... More >> Novartis Investigative Site Alzenau, Germany, 63755 Novartis Investigative Site Bamberg, Germany, 96049 Novartis Investigative Site Leipzig, Germany, 04103 Novartis Investigative Site Würzburg, Germany, 97080 Italy Novartis Investigative Site Ancona, AN, Italy, 60126 Novartis Investigative Site Bari, BA, Italy, 70124 Novartis Investigative Site Bergamo, BG, Italy, 24128 Novartis Investigative Site Montichiari, BS, Italy, 25018 Novartis Investigative Site Chieti, CH, Italy, 66100 Novartis Investigative Site Catania, CT, Italy, 95122 Novartis Investigative Site Catania, CT, Italy, 95123 Novartis Investigative Site Firenze, FI, Italy, 50134 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Pozzilli, IS, Italy, 86077 Novartis Investigative Site Messina, ME, Italy, 98121 Novartis Investigative Site Milano, MI, Italy, 20122 Novartis Investigative Site Milano, MI, Italy, 20132 Novartis Investigative Site Cefalù, PA, Italy, 90015 Novartis Investigative Site Pavia, PV, Italy, 27100 Novartis Investigative Site Roma, RM, Italy, 00133 Novartis Investigative Site Roma, RM, Italy, 00161 Novartis Investigative Site Roma, RM, Italy, 00179 Novartis Investigative Site Roma, RM, Italy, 00189 Novartis Investigative Site Gallarate, VA, Italy, 21013 Novartis Investigative Site Napoli, Italy, 80131 Novartis Investigative Site Napoli, Italy, 80138 Less <<
NCT02799199 - Completed - -
NCT01892722 - Active, not recruiting - -
NCT00289978 Relapsing-remitting Multiple S... More >>clerosis Less << Phase 3 Completed - -
NCT01534182 - Completed - -
NCT01585298 Multiple Sclerosis Phase 4 Completed - -
NCT01534182 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Russian Federation ... More >> Novartis Investigative Site Arkhangelsk, Russia, Russian Federation, 163045 Novartis Investigative Site Barnaul, Russian Federation, 656024 Novartis Investigative Site Belgorod, Russian Federation, 308007 Novartis Investigative Site Kazan, Russian Federation, 420021 Novartis Investigative Site Kemerovo, Russian Federation, 650066 Novartis Investigative Site Khanty-Mansiysk, Russian Federation, 628012 Novartis Investigative Site Kirov, Russian Federation, 610014 Novartis Investigative Site Krasnodar, Russian Federation, 350086 Novartis Investigative Site Kursk, Russian Federation, 305007 Novartis Investigative Site Moscow, Russian Federation, 119992 Novartis Investigative Site Moscow, Russian Federation, 127018 Novartis Investigative Site N.Novgorod, Russian Federation, 603126 Novartis Investigative Site Nizhniy Novgorod, Russian Federation, 603076 Novartis Investigative Site Nizhny Novgorod, Russian Federation, 603155 Novartis Investigative Site Novosibirsk, Russian Federation, 630087 Novartis Investigative Site Perm, Russian Federation, 614990 Novartis Investigative Site Saransk, Russian Federation, 430032 Novartis Investigative Site Saratov, Russian Federation, 410030 Novartis Investigative Site Smolensk, Russian Federation, 214019 Novartis Investigative Site St. Petersburg, Russian Federation, 197376 Novartis Investigative Site Tomsk, Russian Federation, 634050 Novartis Investigative Site Tumen, Russian Federation, 625048 Novartis Investigative Site Tver, Russian Federation, 170036 Novartis Investigative Site Ufa, Russian Federation, 450000 Novartis Investigative Site Ulyanovsk, Russian Federation, 432063 Novartis Investigative Site Yaroslavl, Russian Federation, 150030 Less <<
NCT00340834 Multiple Sclerosis Phase 3 Completed - -
NCT00340834 - Completed - -
NCT01199861 - Completed - -
NCT01442194 - Recruiting December 26, 2022 -
NCT01621269 Multiple Sclerosis PHASE4 WITHDRAWN 2025-06-14 -
NCT00289978 - Completed - -
NCT01623596 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - -
NCT01199861 Relapsing Multiple Sclerosis Phase 3 Completed - Belgium ... More >> Novartis Investigative Site Aalst, Belgium, 9300 Novartis Investigative Site Bruxelles, Belgium, 1200 Novartis Investigative Site Leuven, Belgium, 3000 Novartis Investigative Site Liege, Belgium, 4000 Novartis Investigative Site Wilrijk, Belgium, 2610 Canada, Ontario Novartis Investigative Site Nepean, Ontario, Canada, K2G 6E2 Canada, Quebec Novartis Investigative Site Montreal, Quebec, Canada, H3A 2B4 Canada Novartis Investigative Site Sherbrooke, Canada, JiH 5N4 Finland Novartis Investigative Site Seinajoki, Finland, 60220 Novartis Investigative Site Turku, Finland, 20100 France Novartis Investigative Site Caen, France, 14033 Novartis Investigative Site Rennes, France, 35043 Novartis Investigative Site St Herblain, France, 44800 Novartis Investigative Site Toulouse, France, 31059 Guatemala Novartis Investigative Site Guatemala City, Guatemala, 01010 Novartis Investigative Site Guatemala City, Guatemala, 01014 Poland Novartis Investigative Site Katowice, Poland, 40-594 Novartis Investigative Site Lodz, Poland, 90-153 Spain Novartis Investigative Site Madrid, Spain, 28029 Novartis Investigative Site Madrid, Spain, 28040 Novartis Investigative Site Sevilla, Spain, 41009 Novartis Investigative Site Valencia, Spain, 46009 Switzerland Novartis Investigational Site Basel, Switzerland, 4031 United Kingdom Novartis Investigative Site Nottingham, United Kingdom, NG7 2UH Novartis Investigative Site Stoke-on-Trent, United Kingdom, ST4 7LN Less <<
NCT01310166 Relapsing-remitting Multiple S... More >>clerosis Less << PHASE4 COMPLETED 2025-07-12 Novartis Investigative Site, O... More >>stfildern, Baden-Wuerttemberg, 73760, Germany|Novartis Investigative Site, Aalen, 73430, Germany|Novartis Investigative Site, Abensberg, 93326, Germany|Novartis Investigative Site, Altenholz-Stift, 24161, Germany|Novartis Investigative Site, Alzenau, 63755, Germany|Novartis Investigative Site, Andernach, 56626, Germany|Novartis Investigative Site, Aschaffenburg, 63739, Germany|Novartis Investigative Site, Bad Mergentheim, 97980, Germany|Novartis Investigative Site, Bamberg, 96052, Germany|Novartis Investigative Site, Berg, 82335, Germany|Novartis Investigative Site, Berlin, 10437, Germany|Novartis Investigative Site, Berlin, 10713, Germany|Novartis Investigative Site, Berlin, 12165, Germany|Novartis Investigative Site, Berlin, 13347, Germany|Novartis Investigative Site, Bielefeld, 33611, Germany|Novartis Investigative Site, Bochum, 44787, Germany|Novartis Investigative Site, Bochum, 44789, Germany|Novartis Investigative Site, Bochum, 44791, Germany|Novartis Investigative Site, Bremen, 28755, Germany|Novartis Investigative Site, B?blingen, 71032, Germany|Novartis Investigative Site, Celle, 29223, Germany|Novartis Investigative Site, Dortmund, 44135, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Düsseldorf, 40225, Germany|Novartis Investigative Site, Erbach, 64711, Germany|Novartis Investigative Site, Erlangen, 91054, Germany|Novartis Investigative Site, Frankfurt, 60313, Germany|Novartis Investigative Site, Fulda, 36043, Germany|Novartis Investigative Site, Grevenbroich, 41515, Germany|Novartis Investigative Site, G?ttingen, 37073, Germany|Novartis Investigative Site, Hamburg, 20249, Germany|Novartis Investigative Site, Hamburg, 22083, Germany|Novartis Investigative Site, Hennigsdorf, 16761, Germany|Novartis Investigative Site, Jena, 07740, Germany|Novartis Investigative Site, Kastellaun, 56288, Germany|Novartis Investigative Site, Kiel, 24105, Germany|Novartis Investigative Site, Klingenmünster, 76889, Germany|Novartis Investigative Site, Krefeld, 47800, Germany|Novartis Investigative Site, Lappersdorf, 93138, Germany|Novartis Investigative Site, Leipzig, 04157, Germany|Novartis Investigative Site, Leipzig, 04299, Germany|Novartis Investigative Site, Leverkusen, 51375, Germany|Novartis Investigative Site, Merzig, 66663, Germany|Novartis Investigative Site, M?nchengladbach, 41239, Germany|Novartis Investigative Site, München, 81829, Germany|Novartis Investigative Site, Neuburg, 86633, Germany|Novartis Investigative Site, Osnabrück, 49076, Germany|Novartis Investigative Site, Regensburg, 93053, Germany|Novartis Investigative Site, Schwendi, 88477, Germany|Novartis Investigative Site, Siegen, 57076, Germany|Novartis Investigative Site, Singen, 78224, Germany|Novartis Investigative Site, Stade, 21682, Germany|Novartis Investigative Site, Stadtroda, 07646, Germany|Novartis Investigative Site, Stuttgart, 70178, Germany|Novartis Investigative Site, Troisdorf, 53844, Germany|Novartis Investigative Site, Tübingen, 72076, Germany|Novartis Investigative Site, Ulm, 89073, Germany|Novartis Investigative Site, Unterhaching, 82008, Germany|Novartis Investigative Site, Wermsdorf, 04779, Germany|Novartis Investigative Site, Wolfenbüttel, 38300, Germany Less <<
NCT03257358 Relapsing Multiple Sclerosis PHASE4 COMPLETED 2019-06-28 Novartis Investigative Site, B... More >>irmingham, Alabama, 35209, United States|Novartis Investigative Site, Cullman, Alabama, 35058, United States|Novartis Investigative Site, Tucson, Arizona, 85718, United States|Novartis Investigative Site, Berkeley, California, 94705, United States|Novartis Investigative Site, Sacramento, California, 95817, United States|Novartis Investigative Site, Colorado Springs, Colorado, 80907, United States|Novartis Investigative Site, Louisville, Colorado, 80027, United States|Novartis Investigative Site, Boca Raton, Florida, 33482, United States|Novartis Investigative Site, Boca Raton, Florida, 33487, United States|Novartis Investigative Site, Jacksonville, Florida, 32209, United States|Novartis Investigative Site, Miami, Florida, 33136, United States|Novartis Investigative Site, Ocala, Florida, 34471, United States|Novartis Investigative Site, Port Charlotte, Florida, 33952, United States|Novartis Investigative Site, Sarasota, Florida, 34243, United States|Novartis Investigative Site, Sunrise, Florida, 33351, United States|Novartis Investigative Site, Vero Beach, Florida, 32960, United States|Novartis Investigative Site, Savannah, Georgia, 31406, United States|Novartis Investigative Site, Suwanee, Georgia, 30024, United States|Novartis Investigative Site, Flossmoor, Illinois, 60422, United States|Novartis Investigative Site, Kansas City, Kansas, 66160, United States|Novartis Investigative Site, Louisville, Kentucky, 40202, United States|Novartis Investigative Site, Louisville, Kentucky, 40207, United States|Novartis Investigative Site, Lutherville, Maryland, 21093, United States|Novartis Investigative Site, Foxboro, Massachusetts, 02035, United States|Novartis Investigative Site, Lexington, Massachusetts, 02421, United States|Novartis Investigative Site, Wellesley, Massachusetts, 02481, United States|Novartis Investigative Site, Ann Arbor, Michigan, 48109, United States|Novartis Investigative Site, Owosso, Michigan, 48867, United States|Novartis Investigative Site, Golden Valley, Minnesota, 55422, United States|Novartis Investigative Site, Kansas City, Missouri, 64111, United States|Novartis Investigative Site, Saint Louis, Missouri, 63131, United States|Novartis Investigative Site, Las Vegas, Nevada, 89106, United States|Novartis Investigative Site, Fair Lawn, New Jersey, 07410, United States|Novartis Investigative Site, Livingston, New Jersey, 07039, United States|Novartis Investigative Site, Patchogue, New York, 11772, United States|Novartis Investigative Site, Plainview, New York, 11803, United States|Novartis Investigative Site, Asheville, North Carolina, 28806, United States|Novartis Investigative Site, Charlotte, North Carolina, 28207, United States|Novartis Investigative Site, Mooresville, North Carolina, 28117, United States|Novartis Investigative Site, Raleigh, North Carolina, 27607, United States|Novartis Investigative Site, Winston-Salem, North Carolina, 27103, United States|Novartis Investigative Site, Cleveland, Ohio, 44195, United States|Novartis Investigative Site, Dayton, Ohio, 45408, United States|Novartis Investigative Site, Toledo, Ohio, 43623, United States|Novartis Investigative Site, Westerville, Ohio, 43081, United States|Novartis Investigative Site, Oklahoma City, Oklahoma, 73102, United States|Novartis Investigative Site, Oklahoma City, Oklahoma, 73104, United States|Novartis Investigative Site, Portland, Oregon, 97225, United States|Novartis Investigative Site, Philadelphia, Pennsylvania, 19140, United States|Novartis Investigative Site, Greer, South Carolina, 29650, United States|Novartis Investigative Site, Mount Pleasant, South Carolina, 29464, United States|Novartis Investigative Site, Port Royal, South Carolina, 29935, United States|Novartis Investigative Site, Knoxville, Tennessee, 37922, United States|Novartis Investigative Site, Nashville, Tennessee, 37215, United States|Novartis Investigative Site, Dallas, Texas, 75246, United States|Novartis Investigative Site, San Antonio, Texas, 78258, United States|Novartis Investigative Site, Falls Church, Virginia, 22043, United States|Novartis Investigative Site, Vienna, Virginia, 22182, United States|Novartis Investigative Site, Kirkland, Washington, 98034, United States|Novartis Investigative Site, Seattle, Washington, 98122, United States|Novartis Investigative Site, Spokane, Washington, 99202, United States|Novartis Investigative Site, Tacoma, Washington, 98405, United States|Novartis Investigative Site, Huntington, West Virginia, 25701, United States|Novartis Investigative Site, Green Bay, Wisconsin, 54311, United States|Novartis Investigative Site, Milwaukee, Wisconsin, 53215, United States|Novartis Investigative Site, Neenah, Wisconsin, 54956, United States Less <<
NCT00355134 Multiple Sclerosis Phase 3 Completed - -
NCT01333501 - Completed - -
NCT01623596 - Completed - -
NCT01790269 - Terminated - Germany ... More >> Charité Universitätsmedizin Berlin Berlin, Germany, 10117 Less <<
NCT01791192 Acute Noninfectious Posterior,... More >> Intermediate, or Pan Uveitis Less << Phase 2 Withdrawn October 2014 -
NCT01216072 Relapsing Forms of Multiple Sc... More >>lerosis Less << Phase 4 Completed - -
NCT02048072 Multiple Sclerosis ... More >> Autonomic Nervous System Dysfunction Less << Phase 4 Completed - Switzerland ... More >> Cantonal Hospital St. Gallen St. Gallen, SG, Switzerland, 9000 Less <<
NCT02048072 - Completed - -
NCT01281657 - Completed - -
NCT00670449 Multiple Sclerosis PHASE2 COMPLETED 2025-04-12 Novartis Investigative Site, C... More >>hiba, 276-8524, Japan|Novartis Investigative Site, Ehime, 791-0295, Japan|Novartis Investigative Site, Fukuoka, 807-8555, Japan|Novartis Investigative Site, Gunma, 371-8511, Japan|Novartis Investigative Site, Hyogo, 650-0017, Japan|Novartis Investigative Site, Ibaraki, 305-8576, Japan|Novartis Investigative Site, Kanagawa, 259-1193, Japan|Novartis Investigative Site, Kyoto, 604-8453, Japan|Novartis Investigative Site, Kyoto, 616-8255, Japan|Novartis Investigative Site, Morioka, 020-8505, Japan|Novartis Investigative Site, Niigata, 951-8520, Japan|Novartis Investigative Site, Osaka, 556-0016, Japan|Novartis Investigative Site, Osaka, 589-8511, Japan|Novartis Investigative Site, Osaka, Japan|Novartis Investigative Site, Sapporo, 060-8648, Japan|Novartis Investigative Site, Tochigi, 329-0498, Japan|Novartis Investigative Site, Tokyo, 113-8519, Japan|Novartis Investigative Site, Tokyo, 145-0065, Japan|Novartis Investigative Site, Tokyo, 162-8666, Japan|Novartis Investigative Site, Wakayama, 641-8510, Japan Less <<
NCT00670449 Multiple Sclerosis PHASE2 COMPLETED 2025-04-12 Novartis Investigative Site, C... More >>hiba, 276-8524, Japan|Novartis Investigative Site, Ehime, 791-0295, Japan|Novartis Investigative Site, Fukuoka, 807-8555, Japan|Novartis Investigative Site, Gunma, 371-8511, Japan|Novartis Investigative Site, Hyogo, 650-0017, Japan|Novartis Investigative Site, Ibaraki, 305-8576, Japan|Novartis Investigative Site, Kanagawa, 259-1193, Japan|Novartis Investigative Site, Kyoto, 604-8453, Japan|Novartis Investigative Site, Kyoto, 616-8255, Japan|Novartis Investigative Site, Morioka, 020-8505, Japan|Novartis Investigative Site, Niigata, 951-8520, Japan|Novartis Investigative Site, Osaka, 556-0016, Japan|Novartis Investigative Site, Osaka, 589-8511, Japan|Novartis Investigative Site, Osaka, Japan|Novartis Investigative Site, Sapporo, 060-8648, Japan|Novartis Investigative Site, Tochigi, 329-0498, Japan|Novartis Investigative Site, Tokyo, 113-8519, Japan|Novartis Investigative Site, Tokyo, 145-0065, Japan|Novartis Investigative Site, Tokyo, 162-8666, Japan|Novartis Investigative Site, Wakayama, 641-8510, Japan Less <<
NCT02939079 Multiple Sclerosis Phase 2 Phase 3 Completed - -
NCT02342704 Relapsing-Remitting Multiple S... More >>clerosis Less << Phase 4 Terminated(Business Decision) - -
NCT00355134 - Completed - -
NCT01633112 Relapsing-remitting Multiple S... More >>clerosis (RRMS) Less << Phase 4 Completed - -
NCT02342704 - Terminated(Business Decision) - -
NCT01216072 - Completed - -
NCT01498887 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - -
NCT00662649 - Completed - -
NCT01625182 Chronic Inflammatory Demyelina... More >>ting Polyradiculoneuropathy Less << Phase 3 Completed - -
NCT00662649 Multiple Sclerosis Phase 3 Completed - -
NCT01201356 Relapsing Forms of Multiple Sc... More >>lerosis Less << PHASE3 COMPLETED 2018-10-19 Novartis Investigative Site, C... More >>ullman, Alabama, 35058, United States|Novartis Investigative Site, Oceanside, California, 92056, United States|Novartis Investigative Site, Sacramento, California, 95817, United States|Novartis Investigative Site, San Francisco, California, 94143, United States|Novartis Investigative Site, Washington, District of Columbia, 20007, United States|Novartis Investigative Site, Jacksonville, Florida, 32209, United States|Novartis Investigative Site, Maitland, Florida, 32751, United States|Novartis Investigative Site, Miami, Florida, 33136, United States|Novartis Investigative Site, Sunrise, Florida, 33351, United States|Novartis Investigative Site, Tallahassee, Florida, 32308, United States|Novartis Investigative Site, Tampa, Florida, 33609, United States|Novartis Investigative Site, Vero Beach, Florida, 32960, United States|Novartis Investigative Site, Atlanta, Georgia, 30327, United States|Novartis Investigative Site, Kansas City, Kansas, 66160, United States|Novartis Investigative Site, Lenexa, Kansas, 66212, United States|Novartis Investigative Site, Baltimore, Maryland, 21201, United States|Novartis Investigative Site, Baltimore, Maryland, 21287, United States|Novartis Investigative Site, Kansas City, Missouri, 64111, United States|Novartis Investigative Site, Lebanon, New Hampshire, 03756, United States|Novartis Investigative Site, Albuquerque, New Mexico, 87131-0001, United States|Novartis Investigative Site, New York, New York, 10021, United States|Novartis Investigative Site, Durham, North Carolina, 27710, United States|Novartis Investigative Site, Raleigh, North Carolina, 27607, United States|Novartis Investigative Site, Toledo, Ohio, 43614, United States|Novartis Investigative Site, Oklahoma City, Oklahoma, 73104, United States|Novartis Investigative Site, Tulsa, Oklahoma, 74136, United States|Novartis Investigative Site, Tualatin, Oregon, 97062, United States|Novartis Investigative Site, Pittsburgh, Pennsylvania, 15213, United States|Novartis Investigative Site, Bristol, Tennessee, 37620, United States|Novartis Investigative Site, Nashville, Tennessee, 37212, United States|Novartis Investigative Site, San Antonio, Texas, 78229, United States|Novartis Investigative Site, Burlington, Vermont, 05401, United States|Novartis Investigative Site, Charlottesville, Virginia, 22904, United States|Novartis Investigative Site, Seattle, Washington, 98122, United States|Novartis Investigative Site, Caba, Buenos Aires, 1425, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1181ACH, Argentina|Novartis Investigative Site, Caba, Buenos Aires, C1428AQK, Argentina|Novartis Investigative Site, Capital Federal, Buenos Aires, C1192AAW, Argentina|Novartis Investigative Site, Guaymallen, Mendoza, M5507XAD, Argentina|Novartis Investigative Site, Ciudad de Salta, Provincia De Salta, A4406BPF, Argentina|Novartis Investigative Site, Rosario, Santa Fe, 2000, Argentina|Novartis Investigative Site, San Miguel de Tucumán, Tucumán, 4000, Argentina|Novartis Investigative Site, Cordoba, X5004CDT, Argentina|Novartis Investigative Site, Salta, A4400BKZ, Argentina|Novartis Investigative Site, Camperdown, New South Wales, 2050, Australia|Novartis Investigative Site, Chatswood, New South Wales, 2067, Australia|Novartis Investigative Site, Kogarah, New South Wales, 2217, Australia|Novartis Investigative Site, Liverpool, New South Wales, 2170, Australia|Novartis Investigative Site, North Gosford, New South Wales, 2250, Australia|Novartis Investigative Site, Woodville, South Australia, 5011, Australia|Novartis Investigative Site, Box Hill, Victoria, 3128, Australia|Novartis Investigative Site, Fitzroy, Victoria, 3065, Australia|Novartis Investigative Site, Heidelberg, Victoria, 3084, Australia|Novartis Investigative Site, Parkville, Victoria, 3050, Australia|Novartis Investigative Site, Innsbruck, Tyrol, 6020, Austria|Novartis Investigative Site, Linz, A-4020, Austria|Novartis Investigative Site, Salzburg, 5020, Austria|Novartis Investigative Site, St Poelten, 3100, Austria|Novartis Investigative Site, Vienna, 1010, Austria|Novartis Investigative Site, Vienna, 1090, Austria|Novartis Investigative Site, Aalst, 9300, Belgium|Novartis Investigative Site, Brugge, 8000, Belgium|Novartis Investigative Site, Brussel, 1090, Belgium|Novartis Investigative Site, Bruxelles, 1070, Belgium|Novartis Investigative Site, Bruxelles, 1200, Belgium|Novartis Investigative Site, Charleroi, 6000, Belgium|Novartis Investigative Site, Fraiture En Condroz, 4557, Belgium|Novartis Investigative Site, Leuven, 3000, Belgium|Novartis Investigative Site, Melsbroek, 1820, Belgium|Novartis Investigative Site, Pelt, 3900, Belgium|Novartis Investigative Site, Sijsele, 8340, Belgium|Novartis Investigative Site, Sint-Truiden, 3800, Belgium|Novartis Investigative Site, Wilrijk, 2610, Belgium|Novartis Investigative Site, Porto Alegre, Rio Grande Do Sul, 90610-000, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 20270-004, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 21941-913, Brazil|Novartis Investigative Site, Rio De Janiero, RJ, 20221-161, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90020-090, Brazil|Novartis Investigative Site, Campinas, SP, 13083-970, Brazil|Novartis Investigative Site, Ribeirao Preto, SP, 14048-900, Brazil|Novartis Investigative Site, Edmonton, Alberta, T6G 2G3, Canada|Novartis Investigative Site, Burnaby, British Columbia, V5G 2X6, Canada|Novartis Investigative Site, Vancouver, British Columbia, V6T 1Z3, Canada|Novartis Investigative Site, Victoria, British Columbia, V8R 1J8, Canada|Novartis Investigative Site, Halifax, Nova Scotia, B3H 2Y9, Canada|Novartis Investigative Site, Kingston, Ontario, K7L 2V7, Canada|Novartis Investigative Site, London, Ontario, N6A 5A5, Canada|Novartis Investigative Site, Nepean, Ontario, K2G 6E2, Canada|Novartis Investigative Site, Ottawa, Ontario, K1H 8L6, Canada|Novartis Investigative Site, Toronto, Ontario, M5B 1W8, Canada|Novartis Investigative Site, Greenfield Park, Quebec, J4V 2J2, Canada|Novartis Investigative Site, Montreal, Quebec, H1T 2M4, Canada|Novartis Investigative Site, Montreal, Quebec, H2L 4M1, Canada|Novartis Investigative Site, Montreal, Quebec, H3A 2B4, Canada|Novartis Investigative Site, Sherbrooke, Quebec, J1H 5N4, Canada|Novartis Investigative Site, Regina, Saskatchewan, S4T 1A5, Canada|Novartis Investigative Site, Quebec, G1J 1Z4, Canada|Novartis Investigative Site, Brno, Czech Republic, 656 91, Czechia|Novartis Investigative Site, Olomouc, CZE, 775 20, Czechia|Novartis Investigative Site, Ostrava-Poruba, 708 00, Czechia|Novartis Investigative Site, Pardubice, 532 03, Czechia|Novartis Investigative Site, Plzen - Lochotin, 30460, Czechia|Novartis Investigative Site, Prague 5, 150 00, Czechia|Novartis Investigative Site, Praha, 12808, Czechia|Novartis Investigative Site, Rychnov nad Kneznou, 516 01, Czechia|Novartis Investigative Site, Teplice, 415 29, Czechia|Novartis Investigative Site, Aarhus, DK-8000, Denmark|Novartis Investigative Site, Copenhagen, DK-2100, Denmark|Novartis Investigative Site, Alexandria, 21131, Egypt|Novartis Investigative Site, Cairo, 11566, Egypt|Novartis Investigative Site, Cairo, Egypt|Novartis Investigative Site, Tallinn, 10617, Estonia|Novartis Investigative Site, Helsinki, 00930, Finland|Novartis Investigative Site, Seinajoki, 60220, Finland|Novartis Investigative Site, Tampere, 33100, Finland|Novartis Investigative Site, Turku, 20520, Finland|Novartis Investigative Site, Nancy, Cedex, 54035, France|Novartis Investigative Site, Bordeaux Cedex, F-33076, France|Novartis Investigative Site, Bron, 69677, France|Novartis Investigative Site, CAEN Cedex, 14033, France|Novartis Investigative Site, Clermont-Ferrand Cedex 1, 63003, France|Novartis Investigative Site, Dijon, 21034, France|Novartis Investigative Site, Lille Cedex, 59037, France|Novartis Investigative Site, Marseille cedex 05, 13385, France|Novartis Investigative Site, Montpellier, 34295, France|Novartis Investigative Site, Nice Cedex 1, 06602, France|Novartis Investigative Site, Paris Cedex 13, 75651, France|Novartis Investigative Site, Poissy, 78303, France|Novartis Investigative Site, Rennes, 35043, France|Novartis Investigative Site, St Herblain, 44800, France|Novartis Investigative Site, Strasbourg Cedex, 67091, France|Novartis Investigative Site, Toulouse cedex 9, 31059, France|Novartis Investigative Site, Ostfildern, Baden-Wuerttemberg, 73760, Germany|Novartis Investigative Site, Munich, Bavaria, 81241, Germany|Novartis Investigative Site, Regensburg, Bavaria, 93053, Germany|Novartis Investigative Site, Koeln, Nordrhein-Westfalen, 50937, Germany|Novartis Investigative Site, Aachen, 52062, Germany|Novartis Investigative Site, Aalen, 73430, Germany|Novartis Investigative Site, Abensberg, 93326, Germany|Novartis Investigative Site, Achim, 28832, Germany|Novartis Investigative Site, Alzenau, 63755, Germany|Novartis Investigative Site, Aschaffenburg, 63739, Germany|Novartis Investigative Site, Augsburg, 86179, Germany|Novartis Investigative Site, Bad Honnef, 53604, Germany|Novartis Investigative Site, Bad Krozingen, 79189, Germany|Novartis Investigative Site, Bad Mergentheim, 97980, Germany|Novartis Investigative Site, Bad Neustadt, 97616, Germany|Novartis Investigative Site, Bamberg, 96049, Germany|Novartis Investigative Site, Bamberg, 96052, Germany|Novartis Investigative Site, Bayreuth, 95445, Germany|Novartis Investigative Site, Berlin, 10178, Germany|Novartis Investigative Site, Berlin, 10625, Germany|Novartis Investigative Site, Berlin, 10713, Germany|Novartis Investigative Site, Berlin, 10785, Germany|Novartis Investigative Site, Berlin, 120999, Germany|Novartis Investigative Site, Berlin, 12101, Germany|Novartis Investigative Site, Berlin, 12163, Germany|Novartis Investigative Site, Berlin, 12351, Germany|Novartis Investigative Site, Berlin, 13347, Germany|Novartis Investigative Site, Berlin, 13353, Germany|Novartis Investigative Site, Berlin, 13439, Germany|Novartis Investigative Site, Berlin, 13507, Germany|Novartis Investigative Site, Berlin, 14163, Germany|Novartis Investigative Site, Bielefeld, 33602, Germany|Novartis Investigative Site, Bielefeld, 33611, Germany|Novartis Investigative Site, Bielefeld, 33647, Germany|Novartis Investigative Site, Boblingen, 71032, Germany|Novartis Investigative Site, Bochum, 44787, Germany|Novartis Investigative Site, Bochum, 44789, Germany|Novartis Investigative Site, Bochum, 44892, Germany|Novartis Investigative Site, Bogen, 94327, Germany|Novartis Investigative Site, Bonn, 53111, Germany|Novartis Investigative Site, Buchholz in der Nordheide, 21244, Germany|Novartis Investigative Site, Buchholz, 21244, Germany|Novartis Investigative Site, Chemnitz, 09117, Germany|Novartis Investigative Site, Dillingen, 89407, Germany|Novartis Investigative Site, Dresden, 01307, Germany|Novartis Investigative Site, Düsseldorf, 40211, Germany|Novartis Investigative Site, Emden, 26721, Germany|Novartis Investigative Site, Emmendingen, 79312, Germany|Novartis Investigative Site, Erbach, 64711, Germany|Novartis Investigative Site, Erfurt, 99089, Germany|Novartis Investigative Site, Erlangen, 91054, Germany|Novartis Investigative Site, Essen, 45131, Germany|Novartis Investigative Site, Essen, 45147, Germany|Novartis Investigative Site, Frankfurt, 60590, Germany|Novartis Investigative Site, Freiburg, 79106, Germany|Novartis Investigative Site, Greifswald, 17475, Germany|Novartis Investigative Site, Grevenbroich, 41515, Germany|Novartis Investigative Site, Hamburg, 20099, Germany|Novartis Investigative Site, Hamburg, 20249, Germany|Novartis Investigative Site, Hamburg, 20354, Germany|Novartis Investigative Site, Hamburg, 22083, Germany|Novartis Investigative Site, Hannover, 30161, Germany|Novartis Investigative Site, Hannover, 30171, Germany|Novartis Investigative Site, Hannover, 30625, Germany|Novartis Investigative Site, Heidelberg, 69120, Germany|Novartis Investigative Site, Hennigsdorf, 16761, Germany|Novartis Investigative Site, Herborn, 35745, Germany|Novartis Investigative Site, Homburg, 66421, Germany|Novartis Investigative Site, Ibbenbueren, 49477, Germany|Novartis Investigative Site, Itzehoe, 25524, Germany|Novartis Investigative Site, Jena, 07743, Germany|Novartis Investigative Site, Kaltenkirchen, 24568, Germany|Novartis Investigative Site, Kassel, 34121, Germany|Novartis Investigative Site, Koeln, 51109, Germany|Novartis Investigative Site, Koln, 50935, Germany|Novartis Investigative Site, Krefeld, 47805, Germany|Novartis Investigative Site, Landshut, 84028, Germany|Novartis Investigative Site, Lappersdorf, 93138, Germany|Novartis Investigative Site, Leipzig, 04103, Germany|Novartis Investigative Site, Leipzig, 04275, Germany|Novartis Investigative Site, Lohr am Main, 79816, Germany|Novartis Investigative Site, Ludwigshafen, 67063, Germany|Novartis Investigative Site, Magdeburg, 39120, Germany|Novartis Investigative Site, Mainz, 55131, Germany|Novartis Investigative Site, Mannheim, 68159, Germany|Novartis Investigative Site, Marburg, 35039, Germany|Novartis Investigative Site, Muenchen, 80331, Germany|Novartis Investigative Site, Muenchen, 80377, Germany|Novartis Investigative Site, Muenchen, 81377, Germany|Novartis Investigative Site, Muenster, 48149, Germany|Novartis Investigative Site, München, 81829, Germany|Novartis Investigative Site, Nagold, 72202, Germany|Novartis Investigative Site, Neu-Ulm, 89231, Germany|Novartis Investigative Site, Neuburg an der Donau, 86633, Germany|Novartis Investigative Site, Neuruppin, 16816, Germany|Novartis Investigative Site, Oldenburg, 26122, Germany|Novartis Investigative Site, Osnabrück, 49076, Germany|Novartis Investigative Site, Pforzheim, 75172, Germany|Novartis Investigative Site, Potsdam, 14471, Germany|Novartis Investigative Site, Prien, 83209, Germany|Novartis Investigative Site, Rostock, 18057, Germany|Novartis Investigative Site, Ruelzheim, 76761, Germany|Novartis Investigative Site, Rüdersdorf, 15562, Germany|Novartis Investigative Site, Schwarzenbruck, 90592, Germany|Novartis Investigative Site, Schwendi, 88477, Germany|Novartis Investigative Site, Siegen, 57076, Germany|Novartis Investigative Site, Sinsheim, 74889, Germany|Novartis Investigative Site, Stade, 21682, Germany|Novartis Investigative Site, Stuttgart, 70174, Germany|Novartis Investigative Site, Stuttgart, 70176, Germany|Novartis Investigative Site, Stuttgart, 70178, Germany|Novartis Investigative Site, Stuttgart, 70182, Germany|Novartis Investigative Site, Teupitz, 15755, Germany|Novartis Investigative Site, Trier, 54292, Germany|Novartis Investigative Site, Tübingen, 72076, Germany|Novartis Investigative Site, Ulm, 89073, Germany|Novartis Investigative Site, Ulm, 89081, Germany|Novartis Investigative Site, Unterhaching, 82008, Germany|Novartis Investigative Site, Wendlingen, 73240, Germany|Novartis Investigative Site, Wermsdorf, 04779, Germany|Novartis Investigative Site, Wiesbaden, 65191, Germany|Novartis Investigative Site, Wuerzburg, 97080, Germany|Novartis Investigative Site, Wuppertal, 42283, Germany|Novartis Investigative Site, Würzburg, 97070, Germany|Novartis Investigative Site, Alexandroupolis, Evros, 681 00, Greece|Novartis Investigative Site, Athens, GR, 115 25, Greece|Novartis Investigative Site, Athens, GR, 115 27, Greece|Novartis Investigative Site, Thessaloniki, GR, 570 10, Greece|Novartis Investigative Site, Athens, 106 76, Greece|Novartis Investigative Site, Athens, 115 21, Greece|Novartis Investigative Site, Athens, 11526, Greece|Novartis Investigative Site, Athens, 15123, Greece|Novartis Investigative Site, Heraklion Crete, 711 10, Greece|Novartis Investigative Site, Patras, 265 00, Greece|Novartis Investigative Site, Thessaloniki, 57001, Greece|Novartis Investigative Site, Thessaloniki, GR 54636, Greece|Novartis Investigative Site, Guatemala City, 01010, Guatemala|Novartis Investigative Site, Guatemala City, 01014, Guatemala|Novartis Investigative Site, Budapest, HUN, 1204, Hungary|Novartis Investigative Site, Budapest, 1076, Hungary|Novartis Investigative Site, Budapest, 1085, Hungary|Novartis Investigative Site, Budapest, 1115, Hungary|Novartis Investigative Site, Budapest, 1145, Hungary|Novartis Investigative Site, Debrecen, 4032, Hungary|Novartis Investigative Site, Gyor, 9024, Hungary|Novartis Investigative Site, Miskolc, 3526, Hungary|Novartis Investigative Site, Pecs, 7623, Hungary|Novartis Investigative Site, Szeged, 6725, Hungary|Novartis Investigative Site, Szekesfehervar, H-8000, Hungary|Novartis Investigative Site, Veszprem, H 8200, Hungary|Novartis Investigative Site, Dublin 4, D04 T6F, Ireland|Novartis Investigative Site, Dublin, DUBLIN 9, Ireland|Novartis Investigative Site, Ashkelon, 78278, Israel|Novartis Investigative Site, Haifa, 3436212, Israel|Novartis Investigative Site, Ramat Gan, 52621, Israel|Novartis Investigative Site, Sefad, 13100, Israel|Novartis Investigative Site, Asti, AT, 14100, Italy|Novartis Investigative Site, Acquaviva delle Fonti, BA, 70021, Italy|Novartis Investigative Site, Bergamo, BG, 24127, Italy|Novartis Investigative Site, Bologna, BO, 40139, Italy|Novartis Investigative Site, Montichiari, BS, 25018, Italy|Novartis Investigative Site, Cagliari, CA, 09126, Italy|Novartis Investigative Site, Chieti, CH, 66100, Italy|Novartis Investigative Site, Catania, CT, 95122, Italy|Novartis Investigative Site, Catania, CT, 95123, Italy|Novartis Investigative Site, Cona, FE, 44100, Italy|Novartis Investigative Site, Foggia, FG, 71100, Italy|Novartis Investigative Site, Firenze, FI, 50134, Italy|Novartis Investigative Site, Genova, GE, 16132, Italy|Novartis Investigative Site, Pozzilli, IS, 86077, Italy|Novartis Investigative Site, Roma, Lazio, 00168, Italy|Novartis Investigative Site, Milano, MI, 20122, Italy|Novartis Investigative Site, Milano, MI, 20132, Italy|Novartis Investigative Site, Palermo, PA, 90146, Italy|Novartis Investigative Site, Fidenza, PR, 43036, Italy|Novartis Investigative Site, Pavia, PV, 27100, Italy|Novartis Investigative Site, Ravenna, RA, 48100, Italy|Novartis Investigative Site, Roma, RM, 00133, Italy|Novartis Investigative Site, Roma, RM, 00135, Italy|Novartis Investigative Site, Roma, RM, 00161, Italy|Novartis Investigative Site, Roma, RM, 00189, Italy|Novartis Investigative Site, Siena, SI, 53100, Italy|Novartis Investigative Site, Orbassano, TO, 10043, Italy|Novartis Investigative Site, Udine, UD, 33100, Italy|Novartis Investigative Site, Gallarate, VA, 21013, Italy|Novartis Investigative Site, Vicenza, VI, 36100, Italy|Novartis Investigative Site, Verona, VR, 37134, Italy|Novartis Investigative Site, Viterbo, VT, 01100, Italy|Novartis Investigative Site, Napoli, 80131, Italy|Novartis Investigative Site, Napoli, 80132, Italy|Novartis Investigative Site, Napoli, 80138, Italy|Novartis Investigative Site, Irbid, 22110, Jordan|Novartis Investigative Site, Gyeonggi do, Korea, 10408, Korea, Republic of|Novartis Investigative Site, Seoul, 03722, Korea, Republic of|Novartis Investigative Site, Seoul, 06351, Korea, Republic of|Novartis Investigative Site, Kuala Lumpur, Wilayah Persekutuan, 50586, Malaysia|Novartis Investigative Site, Kuala Lumpur, 59100, Malaysia|Novartis Investigative Site, Breda, CK, 4818, Netherlands|Novartis Investigative Site, Amsterdam, 1061 AE, Netherlands|Novartis Investigative Site, Amsterdam, 1081 HV, Netherlands|Novartis Investigative Site, Blaricum, 1261 AN, Netherlands|Novartis Investigative Site, Enschede, 7513 ER, Netherlands|Novartis Investigative Site, Gouda, 2803 HH, Netherlands|Novartis Investigative Site, Nieuwegein, Netherlands|Novartis Investigative Site, Nijmegen, 6525 GC, Netherlands|Novartis Investigative Site, Rotterdam, 3015 CE, Netherlands|Novartis Investigative Site, Sittard-Geleen, 6162 BG, Netherlands|Novartis Investigative Site, Tilburg, 5022 GC, Netherlands|Novartis Investigative Site, Lillehammer, 2629, Norway|Novartis Investigative Site, Molde, 6412, Norway|Novartis Investigative Site, Stavanger, 4068, Norway|Novartis Investigative Site, Panama City, 0801, Panama|Novartis Investigative Site, Panama City, Panama|Novartis Investigative Site, La Perla, Callao, 04, Peru|Novartis Investigative Site, Jesus Maria, Lima, 11, Peru|Novartis Investigative Site, San Isidro, Lima, 27, Peru|Novartis Investigative Site, Bialystok, 15-276, Poland|Novartis Investigative Site, Bialystok, 15-420, Poland|Novartis Investigative Site, Bydgoszcz, 85 681, Poland|Novartis Investigative Site, Gdansk, 80-803, Poland|Novartis Investigative Site, Katowice, 40 571, Poland|Novartis Investigative Site, Katowice, 40-648, Poland|Novartis Investigative Site, Lodz, 90 324, Poland|Novartis Investigative Site, Poznan, 60-355, Poland|Novartis Investigative Site, Warszawa, 02-097, Poland|Novartis Investigative Site, Warszawa, 02-507, Poland|Novartis Investigative Site, Warszawa, 02-957, Poland|Novartis Investigative Site, Warszawa, 04141, Poland|Novartis Investigative Site, Amadora, 2720-276, Portugal|Novartis Investigative Site, Coimbra, 3000075, Portugal|Novartis Investigative Site, Lisboa, 1150 314, Portugal|Novartis Investigative Site, Porto, 4099-001, Portugal|Novartis Investigative Site, Porto, 4200 319, Portugal|Novartis Investigative Site, Setubal, 2910-446, Portugal|Novartis Investigative Site, Bucharest, 010825, Romania|Novartis Investigative Site, Bucharest, 011461, Romania|Novartis Investigative Site, Bucharest, 050098, Romania|Novartis Investigative Site, Craiova, 200620, Romania|Novartis Investigative Site, Targu Mures, 540136, Romania|Novartis Investigative Site, Samara, Samara Region, 443095, Russian Federation|Novartis Investigative Site, Ekaterinburg, 620109, Russian Federation|Novartis Investigative Site, Kazan, 420021, Russian Federation|Novartis Investigative Site, Kazan, 420097, Russian Federation|Novartis Investigative Site, Moscow, 101990, Russian Federation|Novartis Investigative Site, Moscow, 121359, Russian Federation|Novartis Investigative Site, Moscow, 125367, Russian Federation|Novartis Investigative Site, Moscow, 127018, Russian Federation|Novartis Investigative Site, Nizhny Novgorod, 603018, Russian Federation|Novartis Investigative Site, Nizhny Novgorod, 603155, Russian Federation|Novartis Investigative Site, Saint Petersburg, 194044, Russian Federation|Novartis Investigative Site, Smolensk, 214019, Russian Federation|Novartis Investigative Site, St. Petersburg, 194291, Russian Federation|Novartis Investigative Site, St. Petersburg, 197376, Russian Federation|Novartis Investigative Site, Bratislava, Slovak Republic, 84103, Slovakia|Novartis Investigative Site, Bratislava, 813 69, Slovakia|Novartis Investigative Site, Bratislava, 826 06, Slovakia|Novartis Investigative Site, Martin, 036 59, Slovakia|Novartis Investigative Site, Trnava, 917 75, Slovakia|Novartis Investigative Site, Cape Town, 7925, South Africa|Novartis Investigative Site, Durban, South Africa|Novartis Investigative Site, Rosebank, 2196, South Africa|Novartis Investigative Site, Malaga, Andalucia, 29010, Spain|Novartis Investigative Site, Sevilla, Andalucia, 41009, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08035, Spain|Novartis Investigative Site, Barcelona, Catalunya, 08036, Spain|Novartis Investigative Site, L Hospitalet De Llobregat, Catalunya, 08907, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46010, Spain|Novartis Investigative Site, Valencia, Comunidad Valenciana, 46026, Spain|Novartis Investigative Site, Santiago de Compostela, Galicia, 15706, Spain|Novartis Investigative Site, Bilbao, Pais Vasco, 48013, Spain|Novartis Investigative Site, San Sebastian, Pais Vasco, 20080, Spain|Novartis Investigative Site, Barcelona, 08041, Spain|Novartis Investigative Site, Madrid, 28034, Spain|Novartis Investigative Site, Madrid, 28040, Spain|Novartis Investigative Site, Madrid, 28046, Spain|Novartis Investigative Site, Madrid, 28222, Spain|Novartis Investigative Site, Santa Cruz de Tenerife, 38009, Spain|Novartis Investigative Site, Goeteborg, 413 45, Sweden|Novartis Investigative Site, Linkoping, SE 581 85, Sweden|Novartis Investigative Site, Stockholm, 102 35, Sweden|Novartis Investigative Site, Stockholm, 14186, Sweden|Novartis Investigative Site, Umea, 901 85, Sweden|Novartis Investigative Site, Aarau, 5001, Switzerland|Novartis Investigative Site, Basel, 4031, Switzerland|Novartis Investigative Site, Carouge, 1227, Switzerland|Novartis Investigative Site, Lausanne, 1011, Switzerland|Novartis Investigative Site, Lugano, 6900, Switzerland|Novartis Investigative Site, St Gallen, 9007, Switzerland|Novartis Investigative Site, Zuerich, 8091, Switzerland|Novartis Investigative Site, Istanbul, TUR, 34098, Turkey|Novartis Investigative Site, Ankara, 06100, Turkey|Novartis Investigative Site, Ankara, 06500, Turkey|Novartis Investigative Site, Antalya, 07070, Turkey|Novartis Investigative Site, Gaziantep, 27310, Turkey|Novartis Investigative Site, Haseki / Istanbul, 34096, Turkey|Novartis Investigative Site, Istanbul, 34093, Turkey|Novartis Investigative Site, Istanbul, 34147, Turkey|Novartis Investigative Site, Istanbul, 34722, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Izmir, 35340, Turkey|Novartis Investigative Site, Mersin, 33079, Turkey|Novartis Investigative Site, Samsun, 55139, Turkey|Novartis Investigative Site, Trabzon, 61080, Turkey|Novartis Investigative Site, Yenisehir / Izmir, Turkey|Novartis Investigative Site, Truro, Cornwall, TR1 3LJ, United Kingdom|Novartis Investigative Site, Brighton, East Sussex, BN2 5BE, United Kingdom|Novartis Investigative Site, Salford, Manchester, M6 8HD, United Kingdom|Novartis Investigative Site, Headington, Oxfordshire, OX3 9DU, United Kingdom|Novartis Investigative Site, Sheffield, South Yorkshire, S10 2JF, United Kingdom|Novartis Investigative Site, Stoke on Trent, Staffordshire, ST46QG, United Kingdom|Novartis Investigative Site, Birmingham, B15 2TH, United Kingdom|Novartis Investigative Site, Bristol, BS10 5NB, United Kingdom|Novartis Investigative Site, Dundee, DD1 9SY, United Kingdom|Novartis Investigative Site, Edinburgh, EH4 2XU, United Kingdom|Novartis Investigative Site, Essex, RM7 0BE, United Kingdom|Novartis Investigative Site, Great Yarmouth, NR31 6LA, United Kingdom|Novartis Investigative Site, Liverpool, L9 7LJ, United Kingdom|Novartis Investigative Site, London, SE22 8PT, United Kingdom|Novartis Investigative Site, London, SW17 0QT, United Kingdom|Novartis Investigative Site, London, W8 6RF, United Kingdom|Novartis Investigative Site, Middlesbrough, TS4 3BW, United Kingdom|Novartis Investigative Site, Newcastle Upon Tyne, NE1 4LP, United Kingdom|Novartis Investigative Site, Northampton, NN1 5BD, United Kingdom|Novartis Investigative Site, Nottingham, NG7 2UH, United Kingdom|Novartis Investigative Site, Poole, BH15 2JB, United Kingdom|Novartis Investigative Site, Swindon, SN3 6BB, United Kingdom Less <<
NCT01625182 - Completed - -
NCT02232061 Multiple Sclerosis PHASE4 COMPLETED 2020-01-24 Novartis Investigative Site, G... More >>ent, 9000, Belgium|Novartis Investigative Site, Hasselt, 3500, Belgium|Novartis Investigative Site, Ravensburg, 88212, Germany|Novartis Investigative Site, Napoli, 80131, Italy Less <<
NCT02325440 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Unknown April 2016 Germany ... More >> Universitaetsklinikum Muenster, Department of Neurology Recruiting Muenster, Germany, 48149 Contact: Luisa Klotz, PD Dr. med.    +49 251 83444 ext 52    luisa.klotz@ukmuenster.de    Principal Investigator: Luisa Klotz, PD Dr. med. Less <<
NCT01499667 Relapsing Remitting Multiple S... More >>clerosis (RRMS) Less << Phase 3 Terminated(Based on recent pub... More >>lications, determination of natalizumub washout period was no longer relevant.) Less << - -
NCT03345940 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Recruiting November 30, 2020 Italy ... More >> Fondazione IRCCS Istituto Neurologico C. Besta, Neuroimmunology Unit Recruiting Milan, Italy, 20133 Contact: Silvia Rossi, MD, PhD    +39022394 ext 2471    silvia.rossi@istituto-besta.it    Contact: Renato Mantegazza, MD    +39022394 ext 2321    renato.mantegazza@istituto-besta.it    Principal Investigator: Silvia Rossi, MD, PhD Less <<
NCT02002390 Stroke|Vascular Accident|Cereb... More >>ral Stroke|Ischemic Cerebrovascular Accident|Stroke, Acute Less << PHASE2 COMPLETED 2014-10-01 Tianjin Medical University Gen... More >>eral Hospital, Tianjin, Tianjin, 300052, China Less <<
NCT01420055 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 4 Completed - France ... More >> Novartis Investigative Site Agen Cedex 9, France, 47923 Novartis Investigative Site Amiens Cedex 1, France, 80054 Novartis Investigative Site Angers Cedex 1, France, 49033 Novartis Investigative Site Auxerre, France, 89000 Novartis Investigative Site Avignon, France, 84000 Novartis Investigative Site Bayonne, France, 64109 Novartis Investigative Site Beziers, France, 34525 Novartis Investigative Site Bobigny Cedex, France, 93009 Novartis Investigative Site Brest, France, 29240 Novartis Investigative Site Calais, France, 62107 Novartis Investigative Site Castelnau-le-Lez, France, 34170 Novartis Investigative Site Chambray les Tours, France, 37175 Novartis Investigative Site Cherbourg, France, 50100 Novartis Investigative Site Clermont-Ferrand Cedex 1, France, 63003 Novartis Investigative Site Créteil, France, 94010 Novartis Investigative Site Dijon, France, 21034 Novartis Investigative Site Epinal, France, 88021 Novartis Investigative Site Grenoble Cedex 9, France, 38042 Novartis Investigative Site Hagueneau, France, 67500 Novartis Investigative Site La Rochelle cedex 1, France, 17019 Novartis Investigative Site La Seyne sur mer, France, 83500 Novartis Investigative Site Le Kremlin Bicetre, France, 94275 Novartis Investigative Site Le Mans Cedex 09, France, 72037 Novartis Investigative Site Limoges, France Novartis Investigative Site Lyon, France, 69275 Novartis Investigative Site Marseille, France, 13008 Novartis Investigative Site Marseille, France, 13012 Novartis Investigative Site Metz, France, 57085 Novartis Investigative Site Montpellier, France, 34000 Novartis Investigative Site Montpellier, France, 34295 Novartis Investigative Site Nimes, France, 32900 Novartis Investigative Site Orsay, France, 91401 Novartis Investigative Site Paris, France, 75005 Novartis Investigative Site Poitiers, France, 86021 Novartis Investigative Site Pontoise, France, F-95300 Novartis Investigative Site Reims, France, 51092 Novartis Investigative Site Rennes Cedex, France, 35033 Novartis Investigative Site Roanne, France, 42328 Novartis Investigative Site Saint Aubin sur Scie, France, 76550 Novartis Investigative Site Saint Jean, France, 31243 Novartis Investigative Site Sainte Foy les Lyon, France, 69110 Novartis Investigative Site Saumur, France, 49400 Novartis Investigative Site Strasbourg Cedex, France, 67091 Novartis Investigative Site Talant, France, 21240 Novartis Investigative Site Toulouse, France, 31059 Novartis Investigative Site Tourcoing, France, 59200 Novartis Investigative Site Tours Cedex, France, 37044 Less <<
NCT02373098 Relapsing Remitting Multiple S... More >>clerosis Less << Phase 4 Completed - Turkey ... More >> Novartis Investigative Site Istanbul, Turkey, 34093 Novartis Investigative Site Mecidiyekoy/Istanbul, Turkey, 34394 Novartis Investigative Site Uskudar / Istanbul, Turkey, 34668 Less <<
NCT01757691 Acute Demylelinating Optic Neu... More >>ritis Less << Phase 2 Terminated(Discontinuation of ... More >>this study was based on Novartis decision to discontinue development of fingolimod for the treatment of ADON) Less << - United States, Florida ... More >> Novartis Investigative Site St. Petersburg, Florida, United States, 33713 Spain Novartis Investigative Site Majadahonda, Madrid, Spain, 28222 Less <<
NCT01497262 Multiple Sclerosis PHASE3 COMPLETED 2025-04-14 Novartis Investigative Site, C... More >>aba, Buenos Aires, 1425, Argentina|Novartis Investigative Site, Guaymallen, Mendoza, M5507XAD, Argentina|Novartis Investigative Site, San Miguel de Tucuman, Tucumán, T4000DPB, Argentina|Novartis Investigative Site, San Miguel de Tucumán, Tucumán, 4000, Argentina|Novartis Investigative Site, Cordoba, X5004CDT, Argentina|Novartis Investigative Site, Salta, A4400ANG, Argentina|Novartis Investigative Site, Salta, A4400BKZ, Argentina|Novartis Investigative Site, Rio de Janeiro, RJ, 20270-004, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 21941-590, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90610-000, Brazil|Novartis Investigative Site, Barranquilla, Atlantico, Colombia|Novartis Investigative Site, Bogotá, Cundinamarca, 110111, Colombia|Novartis Investigative Site, Bogotá, 00000, Colombia|Novartis Investigative Site, Bogotá, Colombia|Novartis Investigative Site, Cali, Colombia|Novartis Investigative Site, Amman, 11942, Jordan|Novartis Investigative Site, Irbid, 22110, Jordan|Novartis Investigative Site, Kuala Lumpur, 50586, Malaysia|Novartis Investigative Site, Kuala Lumpur, 59100, Malaysia|Novartis Investigative Site, Penang, 10990, Malaysia|Novartis Investigative Site, Mexico, Distrito Federal, 06700, Mexico|Novartis Investigative Site, México, Distrito Federal, 10700, Mexico|Novartis Investigative Site, Monterrey, Nuevo León, 64060, Mexico|Novartis Investigative Site, San Nicolas De Los Garza, Nuevo León, 66480, Mexico|Novartis Investigative Site, San Luis Potosí, 78240, Mexico|Novartis Investigative Site, Panama City, Panamá, Panama|Novartis Investigative Site, La Perla, Callao, 04, Peru|Novartis Investigative Site, Jesus Maria, Lima, 11, Peru|Novartis Investigative Site, San Isidro, Lima, 27, Peru Less <<
NCT01497262 Multiple Sclerosis PHASE3 COMPLETED 2025-04-14 Novartis Investigative Site, C... More >>aba, Buenos Aires, 1425, Argentina|Novartis Investigative Site, Guaymallen, Mendoza, M5507XAD, Argentina|Novartis Investigative Site, San Miguel de Tucuman, Tucumán, T4000DPB, Argentina|Novartis Investigative Site, San Miguel de Tucumán, Tucumán, 4000, Argentina|Novartis Investigative Site, Cordoba, X5004CDT, Argentina|Novartis Investigative Site, Salta, A4400ANG, Argentina|Novartis Investigative Site, Salta, A4400BKZ, Argentina|Novartis Investigative Site, Rio de Janeiro, RJ, 20270-004, Brazil|Novartis Investigative Site, Rio de Janeiro, RJ, 21941-590, Brazil|Novartis Investigative Site, Porto Alegre, RS, 90610-000, Brazil|Novartis Investigative Site, Barranquilla, Atlantico, Colombia|Novartis Investigative Site, Bogotá, Cundinamarca, 110111, Colombia|Novartis Investigative Site, Bogotá, 00000, Colombia|Novartis Investigative Site, Bogotá, Colombia|Novartis Investigative Site, Cali, Colombia|Novartis Investigative Site, Amman, 11942, Jordan|Novartis Investigative Site, Irbid, 22110, Jordan|Novartis Investigative Site, Kuala Lumpur, 50586, Malaysia|Novartis Investigative Site, Kuala Lumpur, 59100, Malaysia|Novartis Investigative Site, Penang, 10990, Malaysia|Novartis Investigative Site, Mexico, Distrito Federal, 06700, Mexico|Novartis Investigative Site, México, Distrito Federal, 10700, Mexico|Novartis Investigative Site, Monterrey, Nuevo León, 64060, Mexico|Novartis Investigative Site, San Nicolas De Los Garza, Nuevo León, 66480, Mexico|Novartis Investigative Site, San Luis Potosí, 78240, Mexico|Novartis Investigative Site, Panama City, Panamá, Panama|Novartis Investigative Site, La Perla, Callao, 04, Peru|Novartis Investigative Site, Jesus Maria, Lima, 11, Peru|Novartis Investigative Site, San Isidro, Lima, 27, Peru Less <<
NCT01757691 - Terminated(Discontinuation of ... More >>this study was based on Novartis decision to discontinue development of fingolimod for the treatment of ADON) Less << - -
NCT01779700 Schizophrenia Phase 2 Active, not recruiting December 2017 United States, Indiana ... More >> Center for NeuroImaging Indianapolis, Indiana, United States, 46202 Prevention and Recovery Center Indianapolis, Indiana, United States, 46202 Larue D Carter Memorial Hospital Indianapolis, Indiana, United States, 46222 Less <<
NCT01578330 Multiple Sclerosis|Relapsing-R... More >>emitting Less << PHASE4 COMPLETED 2025-04-15 Novartis Investigative Site, A... More >>ltunizade, 34662, Turkey|Novartis Investigative Site, Ankara, 06100, Turkey|Novartis Investigative Site, Ankara, 06500, Turkey|Novartis Investigative Site, Atakum / Samsun, 55139, Turkey|Novartis Investigative Site, Bursa, 16059, Turkey|Novartis Investigative Site, Fatih / Istanbul, 34098, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Kocaeli, 41380, Turkey|Novartis Investigative Site, Mecidiyekoy/Istanbul, 34394, Turkey|Novartis Investigative Site, Trabzon, 61080, Turkey|Novartis Investigative Site, Uskudar / Istanbul, 34668, Turkey Less <<
NCT01786174 Amyotrophic Lateral Sclerosis Phase 2 Completed - United States, California ... More >> University of California, Irvine Orange, California, United States, 92868 United States, Georgia Georgia Regents University Augusta, Georgia, United States, 30912 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Texas Methodist Neurological Institute Houston, Texas, United States, 77030 Less <<
NCT01499667 - Terminated(Based on recent pub... More >>lications, determination of natalizumub washout period was no longer relevant.) Less << - -
NCT01786174 - Completed - -
NCT01941004 Multiple Sclerosis (Relapsing ... More >>Remitting) Less << Phase 3 Withdrawn May 2017 -
NCT01578330 Multiple Sclerosis|Relapsing-R... More >>emitting Less << PHASE4 COMPLETED 2025-04-15 Novartis Investigative Site, A... More >>ltunizade, 34662, Turkey|Novartis Investigative Site, Ankara, 06100, Turkey|Novartis Investigative Site, Ankara, 06500, Turkey|Novartis Investigative Site, Atakum / Samsun, 55139, Turkey|Novartis Investigative Site, Bursa, 16059, Turkey|Novartis Investigative Site, Fatih / Istanbul, 34098, Turkey|Novartis Investigative Site, Izmir, 35040, Turkey|Novartis Investigative Site, Kocaeli, 41380, Turkey|Novartis Investigative Site, Mecidiyekoy/Istanbul, 34394, Turkey|Novartis Investigative Site, Trabzon, 61080, Turkey|Novartis Investigative Site, Uskudar / Istanbul, 34668, Turkey Less <<
NCT02061137 Rett's Syndrome Phase 1 Phase 2 Completed - Switzerland ... More >> Department of Neuropediatrics - University Children's Hospital Basel, Switzerland, 4056 Less <<
NCT03216915 - Recruiting December 31, 2019 Germany ... More >> University Medical Hospital Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Christoph Heesen, MD    +49 (0) 40 7410 - 52124    heesen@uke.de    Contact: Ruken Özge Akbulak, MD    +49 (0) 40 7410 - 59471    r.akbulak@uke.de Less <<
NCT01755871 Relapsing Remitting Multiple S... More >>clerosis Less << PHASE4 TERMINATED 2025-02-16 Heinrich Heine Universit?t Düs... More >>seldorf, Düsseldorf, Nord-Rhein Westfahlen, 40225, Germany Less <<
NCT02490930 Glioblastoma|Anaplastic Astroc... More >>ytoma Less << EARLY_PHASE1 COMPLETED 2025-09-17 The Johns Hopkins University, ... More >>Baltimore, Maryland, 21287, United States Less <<
NCT02956200 Stroke|Inflammation PHASE2 WITHDRAWN 2025-12-18 The second affiliated hospital... More >> of Zhejiang University, Hangzhou, Zhejiang, 310000, China Less <<
NCT02137707 - Completed - Canada, British Columbia ... More >> University of British Columbia Vancouver, British Columbia, Canada, V6T 1Z3 Canada, Nova Scotia Dalhousie University Multiple Sclerosis Research Unit Halifax, Nova Scotia, Canada Canada, Ontario Ottawa General Hospital Ottawa, Ontario, Canada, K1H 8L6 Canada, Quebec Clinique Neuro Rive-Sud Greenfield Park, Quebec, Canada Montreal Neurological Institute Montreal, Quebec, Canada, H3A 2B4 Centre hospitalier de l'Universite de Montreal (CHUM) Montréal, Quebec, Canada Less <<
NCT03757338 Healthy Volunteers Phase 1 Completed - New Zealand ... More >> Zenith Clinical Site Dunedin, New Zealand, 9010 Less <<
NCT02575365 Cognition Bra... More >>in Volume Loss Less << Phase 4 Terminated - Turkey ... More >> Novartis Investigative Site Bursa, Turkey, 16059 Novartis Investigative Site Kocaeli, Turkey, 41380 Novartis Investigative Site Kutahya, Turkey, 43000 Less <<
NCT04629872 Stroke Inflammation PHASE2 UNKNOWN 2023-12-30 The First Affiliated Hospital ... More >>of Fujian Medical University, Fuzhou, 350000, China Less <<
NCT06087965 Intracerebral Hemorrhage PHASE1|PHASE2 NOT_YET_RECRUITING 2025-12-30 -
NCT04480853 Multiple Sclerosis PHASE4 RECRUITING 2026-01-27 Novartis Investigative Site, K... More >>aohsiung, 83301, Taiwan|Novartis Investigative Site, Taichung, 407219, Taiwan|Novartis Investigative Site, Tainan, 70403, Taiwan|Novartis Investigative Site, Taipei, 10002, Taiwan|Novartis Investigative Site, Taipei, 11220, Taiwan|Novartis Investigative Site, Taoyuan, 33305, Taiwan Less <<
NCT05141669 Multiple Sclerosis COMPLETED 2020-11-20 Novartis Investigational Site,... More >> East Hanover, New Jersey, 07936-1080, United States Less <<
NCT05423769 Relapsing-Remitting Multiple S... More >>clerosis Less << COMPLETED 2023-11-30 Neuropsychiatry department, Fa... More >>culty of Medicine, Alexandria University Hospitals, Hadra University Hospital, Alexandria, Egypt|Faculty of medicine Ain shams Research Institute-Clinical Research Center (MASRI-CRC), Cairo, Egypt Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.25mL

0.65mL

0.33mL

16.26mL

3.25mL

1.63mL

32.52mL

6.50mL

3.25mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories